DYNLL1 and esophageal squamous cell carcinoma: To investigate the clinical effects of DYNLL1-AS1 in patients with ESCC, the DYNLL1-AS1 levels were detected in the samples collected from patients with neoadjuvant immunotherapy, surgery and radiotherapy.